| 000 | 01753 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516235119.0 | ||
| 264 | 0 | _c20150519 | |
| 008 | 201505s 0 0 eng d | ||
| 022 | _a1365-2125 | ||
| 024 | 7 |
_a10.1111/bcp.12336 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Meng-Ting | |
| 245 | 0 | 0 |
_aAntithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cSep 2014 |
||
| 300 |
_a619-29 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntithyroid Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCarbimazole _xadministration & dosage |
| 650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xepidemiology |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDatabases, Factual |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperthyroidism _xdrug therapy |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethimazole _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 |
_aPropylthiouracil _xadministration & dosage |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTaiwan |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aLee, Wan-Ju | |
| 700 | 1 | _aHuang, Tien-Yu | |
| 700 | 1 | _aChu, Che-Li | |
| 700 | 1 | _aHsieh, Chang-Hsun | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 78 _gno. 3 _gp. 619-29 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bcp.12336 _zAvailable from publisher's website |
| 999 |
_c24245098 _d24245098 |
||